Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H11ClN4OS.CH4O3S |
| Molecular Weight | 402.876 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.C[C@H](SC1=NC(Cl)=CC(N)=N1)C2=CC3=C(OC=C3)C=N2
InChI
InChIKey=DACCRIAOWPHTII-FJXQXJEOSA-N
InChI=1S/C13H11ClN4OS.CH4O3S/c1-7(20-13-17-11(14)5-12(15)18-13)9-4-8-2-3-19-10(8)6-16-9;1-5(2,3)4/h2-7H,1H3,(H2,15,17,18);1H3,(H,2,3,4)/t7-;/m0./s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant. | 2002-03 |
|
| (-)-6-Chloro-2-[(1-furo[2, 3-c]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitor. | 1998-04-23 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7QH6XJ3PLD
Created by
admin on Mon Mar 31 18:08:58 GMT 2025 , Edited by admin on Mon Mar 31 18:08:58 GMT 2025
|
PRIMARY | |||
|
131842441
Created by
admin on Mon Mar 31 18:08:58 GMT 2025 , Edited by admin on Mon Mar 31 18:08:58 GMT 2025
|
PRIMARY | |||
|
185220-05-7
Created by
admin on Mon Mar 31 18:08:58 GMT 2025 , Edited by admin on Mon Mar 31 18:08:58 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
